Search

Your search keyword '"Wolfert MA"' showing total 68 results

Search Constraints

Start Over You searched for: Author "Wolfert MA" Remove constraint Author: "Wolfert MA"
68 results on '"Wolfert MA"'

Search Results

2. Program and abstracts for the 2011 Meeting of the Society for Glycobiology

Catalog

Books, media, physical & digital resources

3. Morphological changes in diabetic kidney are associated with increased O-GlcNAcylation of cytoskeletal proteins including α-actinin 4

4. Structure-Based Design and Synthesis of Lipid A Derivatives to Modulate Cytokine Responses.

5. Chemoenzymatic Synthesis of Tri-antennary N-Glycans Terminating in Sialyl-Lewis x Reveals the Importance of Glycan Complexity for Influenza A Virus Receptor Binding.

6. Antibacterial and anti-inflammatory properties of host defense peptides against Staphylococcus aureus .

7. Heparan Sulfate Proteoglycans as Attachment Factor for SARS-CoV-2.

8. The 3- O -sulfation of heparan sulfate modulates protein binding and lyase degradation.

9. Mono- and Di-Fucosylated Glycans of the Parasitic Worm S. mansoni are Recognized Differently by the Innate Immune Receptor DC-SIGN.

10. Chemoenzymatic Synthesis of Campylobacter jejuni Lipo-oligosaccharide Core Domains to Examine Guillain-Barré Syndrome Serum Antibody Specificities.

11. Mutation of the second sialic acid-binding site of influenza A virus neuraminidase drives compensatory mutations in hemagglutinin.

12. Chemoenzymatic synthesis of the oligosaccharide moiety of the tumor-associated antigen disialosyl globopentaosylceramide.

13. Protecting-Group-Controlled Enzymatic Glycosylation of Oligo-N-Acetyllactosamine Derivatives.

14. N-Glycolylneuraminic Acid as a Receptor for Influenza A Viruses.

15. Synthesis and Immunological Evaluation of a Multicomponent Cancer Vaccine Candidate Containing a Long MUC1 Glycopeptide.

16. Heparan Sulfate Microarray Reveals That Heparan Sulfate-Protein Binding Exhibits Different Ligand Requirements.

17. Synthesis of asymmetrical multiantennary human milk oligosaccharides.

18. Mucin architecture behind the immune response: design, evaluation and conformational analysis of an antitumor vaccine derived from an unnatural MUC1 fragment.

19. Controlled Multi-functionalization Facilitates Targeted Delivery of Nanoparticles to Cancer Cells.

20. MUC1 Vaccines, Comprised of Glycosylated or Non-Glycosylated Peptides or Tumor-Derived MUC1, Can Circumvent Immunoediting to Control Tumor Growth in MUC1 Transgenic Mice.

21. Linear synthesis and immunological properties of a fully synthetic vaccine candidate containing a sialylated MUC1 glycopeptide.

22. A multifunctional anomeric linker for the chemoenzymatic synthesis of complex oligosaccharides.

23. Immune and anticancer responses elicited by fully synthetic aberrantly glycosylated MUC1 tripartite vaccines modified by a TLR2 or TLR9 agonist.

24. Selective exo-enzymatic labeling of N-glycans on the surface of living cells by recombinant ST6Gal I.

25. Adaptive immune activation: glycosylation does matter.

26. Abnormal accumulation and recycling of glycoproteins visualized in Niemann-Pick type C cells using the chemical reporter strategy.

27. Chemical synthesis and immunological evaluation of the inner core oligosaccharide of Francisella tularensis.

28. Polar dibenzocyclooctynes for selective labeling of extracellular glycoconjugates of living cells.

29. Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine.

30. Strain-promoted alkyne-azide cycloadditions (SPAAC) reveal new features of glycoconjugate biosynthesis.

31. Multifunctional surface modification of gold-stabilized nanoparticles by bioorthogonal reactions.

32. Surface modification of polymeric micelles by strain-promoted alkyne-azide cycloadditions.

33. Surface functionalization using catalyst-free azide-alkyne cycloaddition.

34. Differential induction of innate immune responses by synthetic lipid a derivatives.

35. Innate immune responses of primary murine macrophage-lineage cells and RAW 264.7 cells to ligands of Toll-like receptors 2, 3, and 4.

36. Glycopeptide-specific monoclonal antibodies suggest new roles for O-GlcNAc.

38. Chemical synthesis and proinflammatory responses of monophosphoryl lipid A adjuvant candidates.

39. Selective labeling of living cells by a photo-triggered click reaction.

40. Binding and Cellular Activation Studies Reveal That Toll-like Receptor 2 Can Differentially Recognize Peptidoglycan from Gram-positive and Gram-negative Bacteria.

41. Increasing the antigenicity of synthetic tumor-associated carbohydrate antigens by targeting Toll-like receptors.

42. Synthetic tetra-acylated derivatives of lipid A from Porphyromonas gingivalis are antagonists of human TLR4.

43. Chemical synthesis and immunological properties of oligosaccharides derived from the vegetative cell wall of Bacillus anthracis.

44. Visualizing metabolically labeled glycoconjugates of living cells by copper-free and fast huisgen cycloadditions.

45. Innate immune responses of synthetic lipid A derivatives of Neisseria meningitidis.

46. Robust immune responses elicited by a fully synthetic three-component vaccine.

47. The influence of the long chain fatty acid on the antagonistic activities of Rhizobium sin-1 lipid A.

48. Agonistic and antagonistic properties of a Rhizobium sin-1 lipid A modified by an ether-linked lipid.

49. Modulation of innate immune responses with synthetic lipid A derivatives.

50. Modification of the structure of peptidoglycan is a strategy to avoid detection by nucleotide-binding oligomerization domain protein 1.